Page 59 - CIBERSAM2016-ENG

Most relevant scientific articles
• Martinez-Cengotitabengoa M, MacDowell KS, Alberich S, Diaz FJ, Garcia-Bueno B, Rodriguez- Jimenez R et al. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.Schizophrenia bulletin. 2016.
• Sanada K., Zorrilla I., Iwata Y., Bermudez-Ampudia C., Graff-Guerrero A., Martinez-Cengotitabengoa M. et al. The efficacy of non-pharmacological interventions on brain-derived neurotrophic factor in schizophrenia: A systematic review and meta-analysis. International Journal of Molecular Sciences. 2016;17(10).
• Garcia S., Martinez-Cengotitabengoa M., Lopez-Zurbano S., Zorrilla I., Lopez P., Vieta E. et al. Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review. Journal of Clinical Psychopharmacology. 2016.
• González-Pinto A, González-Ortega I, Alberich S, Ruiz de Azúa S, Bernardo M, Bioque M et al. Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.PloS one. 2016;11(8): e0160949.
• Martin-Carrasco M., Evans-Lacko S., Dom G., Christodoulou N.G., Samochowiec J., Gonzalez- Fraile E. et al. EPA guidance on mental health and economic crises in Europe. European Archives of Psychiatry and Clinical Neuroscience. 2016;1-36.
Hightlights
The G10 group led by Ana González-Pinto has participated in several projects in 2006, such as the Mastermind project for the treatment of Depression focusing on telemedicine, the implementation of technology to Psychiatry and the improvement of clinical outcomes.
The group has also led 6 competitive national projects (ISCIII), being specially noteworthy the project on therapeutic adherence in First-Episode Psychosis (FEP) within SEPs study, the continuation in the Cognitive Behavioural Therapy for FEP and cannabis abuse, the project for Cognitive Therapy based on mindfulness for Bipolar Disorder and the study about the functioning of patients with suicidal behaviour. Moreover, two projects have been funded by Gobierno Vasco and another one received a grant for research groups from UPV/EHU.
As for collaborative projects, the participation on the study of infant maltreatment led by Dr Fañanas (G8) for the improvement of child mental health should be emphasized. Futhermore, the project led by Dr Molina (G19) which studies brain connectivity alterations in Schizophrenia, and the PEPs study directed by Dr Bernando (G4) are also remarkable.
Besides, the group set a milestone with the national patent “In vitro method and kit for the prognosis or prediction of response to treatment with antipsychotic agents in patients who have suffered a FEP”, as well as with the designation of Dr González-Pinto as president of SEPB.
Finally, the incorporation of new talents into research through internship training in the group and the completion of doctoral theses continues to be a priority in this group, having worked with Dr Kenji Sanada from Tokyo and Dr Zorrilla having defended his doctoral thesis on the long-term prognosis of Bipolar Disoder with mixed episodes.
SAM
research groups 59